These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27333968)

  • 21. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
    Gutwinski S; Müller P; Koller M
    Psychiatr Prax; 2007 Sep; 34(6):289-91. PubMed ID: 17806015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Typical and atypical antipsychotics: Is there a difference in their influence on neurocognition?].
    Faber G; van Gool AR; Smid HG; Wiersma D; van den Bosch RJ
    Tijdschr Psychiatr; 2011; 53(2):107-17. PubMed ID: 21319067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolongation of QTc interval and antipsychotics.
    Agelink MW
    Am J Psychiatry; 2002 Jun; 159(6):1063; author reply 1064. PubMed ID: 12042206
    [No Abstract]   [Full Text] [Related]  

  • 24. Addition of antipsychotics to medication regimens during schizophrenic inpatient care.
    Koyama A; Ito H; Nakanishi M; Sawamura K; Higuchi T
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):56-64. PubMed ID: 18289142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences of satisfaction with medication between patients with schizophrenia treated with typical antipsychotics and atypical antipsychotics.
    Watanabe A; Shibata I; Kato T
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):268-73. PubMed ID: 15149292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of neuroleptic drugs in selenium deficiency and sudden death of cardiac origin: study and human post-mortem examination.
    Hamdan L; Bost M; Chazot G; Bui-Xuan B; Vaillant F; Dehina L; Descotes J; Tabib A; Mamou Z; Timour Q
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):170-3. PubMed ID: 22664334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia.
    Nakanishi S; Kunugi H; Murray RM; Nojima S; Ogawa T; Takahashi T
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):751-7. PubMed ID: 17109710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal cord injury: a role for the psychiatrist.
    Stewart TD
    Am J Psychiatry; 1977 May; 134(5):538-41. PubMed ID: 15463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypomania induced by atypical antipsychotics among schizophrenic patients: report of three cases.
    Baldaçara L; de Castro Ferrari MC; Monteiro BF; Uchida RR; Sanches M
    Pharmacopsychiatry; 2007 Jul; 40(4):169-70. PubMed ID: 17694481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excessive dosing and polypharmacy of antipsychotics caused by pro re nata in agitated patients with schizophrenia.
    Fujita J; Nishida A; Sakata M; Noda T; Ito H
    Psychiatry Clin Neurosci; 2013 Jul; 67(5):345-51. PubMed ID: 23711166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenothiazine deaths: a critical review.
    Peele R; Von Loetzen IS
    Am J Psychiatry; 1973 Mar; 130(3):306-9. PubMed ID: 4143945
    [No Abstract]   [Full Text] [Related]  

  • 32. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [From neuroleptics toward antipsychotics: quality of life and schizophrenia].
    Lançon C
    Encephale; 2003 Sep; 29(Pt 2):S43-6. PubMed ID: 14710537
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk of cardiovascular disease and sudden death in schizophrenia.
    Davidson M
    J Clin Psychiatry; 2002; 63 Suppl 9():5-11. PubMed ID: 12088174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment-resistant schizophrenia: reviewing the options and identifying the way forward.
    Hellewell JS
    J Clin Psychiatry; 1999; 60 Suppl 23():14-9. PubMed ID: 10625195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study.
    Watanabe J; Suzuki Y; Fukui N; Ono S; Sugai T; Tsuneyama N; Someya T
    J Clin Psychopharmacol; 2012 Feb; 32(1):18-22. PubMed ID: 22198445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influences of second generation antipsychotics on the course of schizophrenia].
    Messer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S161-3. PubMed ID: 15570540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lifelong relapse prevention with antipsychotics in schizophrenia].
    Hasan A; Wobrock T
    Psychiatr Prax; 2010 Sep; 37(6):268-70. PubMed ID: 20803409
    [No Abstract]   [Full Text] [Related]  

  • 39. [Heart rate variability in schizophrenic patients treated with antipsychotic agents].
    Cohen H; Loewenthal U; Matar M; Kotler M
    Harefuah; 2001 Dec; 140(12):1142-7, 1231. PubMed ID: 11789296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Theory in antipsychotic drug therapy for schizophrenia].
    Tomioka S; Ishigooka J
    Seishin Shinkeigaku Zasshi; 2006; 108(6):614-8. PubMed ID: 16910539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.